Michael H. Criqui, M.D., M.P.H., is Distinguished Professor and Chief, Division of Preventive Medicine, in the Department of Family and Preventive Medicine at the University of California, San Diego (UCSD) School of Medicine. He also holds a joint appointment as Distinguished Professor, Division of Cardiology, in the Department of Medicine at UCSD, and he is Director of the Preventive Cardiology Academic Award Program at UCSD. Dr Criqui received his medical degree and did his residency training at the University of California, San Francisco and received his Master of Public Health degree in epidemiology from the University of California, Berkeley. He is Board Certified in General Preventive Medicine by the American College of Preventive Medicine.
Dr. Criqui is an active and productive investigator in cardiovascular epidemiology and preventive cardiology, and has made seminal contributions in the fields of subclinical atherosclerosis, peripheral arterial disease, and peripheral venous disease. He has published over 425 manuscripts and book chapters, and has been an invited lecturer at numerous national and international medical meetings. He is the recipient of several research grants and contracts, and is currently the Director of the NHLBI funded training program at UCSD in cardiovascular epidemiology and prevention. He has mentored numerous students, residents and fellows.
Dr. Criqui is a Fellow of the following societies: the American College of Preventive Medicine, the American College of Epidemiology, the Society for Vascular Medicine, the Council on Peripheral Vascular Disease of the American Heart Association, and the Council on Epidemiology and Prevention of the American Heart Association, for which he served as Chair. He is past Chair of the Interdisciplinary Committee on Prevention for the American Heart Association. . He currently chairs the International Peripheral Arterial Disease Working Group, for the Global Burden of Diseases, Injuries, and Risk Factors Study. He has served on committees for the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control, the World Health Organization, and the Institute of Medicine.
He is the recipient of several honors including election to the American Epidemiological Society (1984), the Joseph E. Stokes III Preventive Cardiology Award from the American Society for Preventive Cardiology (2001), the Frederick H. Epstein Memorial Lecture Award from the European Society of Cardiology Working Group on Epidemiology and Prevention (2002), the Special Recognition Award from AHA Council on Epidemiology and Prevention (2004), the Distinguished Achievement Award from the AHA Council on Epidemiology and Prevention (2008), the President’s Award for Vision from the Vascular Disease Foundation (2010), and the Marcus Award for Distinguished Contribution as a Gifted Teacher from the International Academy of Cardiology (2011). In 2010, he was named a Distinguished Scientist of the American Heart Association, the organization’s highest scientific award.
Dr Allison is a Diplomat of the American Board of Preventive Medicine and a member of the American Heart Association’s Council on Epidemiology and Prevention. He is the past Chair of the Early Career and Minority Committees for this Council.
Dr. Anderson's research focuses on nutrition and chronic disease prevention. She is an active researcher in cardiovascular epidemiology, and is the principal investigator of an NHLBI-funded study of the effects of dietary sodium and potassium intake on cardiovascular disease. She is the also the principal investigator of a behavioral intervention study for adherence to current dietary sodium recommendations. She is a co-investigator on the NIDDK-funded national multicenter Chronic Renal Insufficiency Cohort Study, which aims to identify risk factors and mechanisms of progressive renal disease and cardiovascular events in individuals with chronic kidney disease.
Dr. Anderson is a Fellow of the American Heart Association, and is a member of the leadership committee of the American Heart Association's councils on Epidemiology and Nutrition Physical Activity and Metabolism. She is also a member of the Pan American Health Organization’s (PAHO) Expert Group on Cardiovascular Disease Prevention through Dietary Salt Reduction, and the World Health Organization’s International Agency for Research on Cancer (IARC) committee on nutrition and physical (in)activity as determinants of cancer risk in Africa. She has also served on committees of the institute of Medicine (IOM), and in 2011 was appointed to the IOM’s standing Food and Nutrition Board. Additional honors and awards include the prestigious Gil Omenn Award for Academic Excellence (2001), Dannon Nutrition Leadership Institute Scholar (2003), and a Volunteer Service Award from the National Kidney Foundation of Maryland (2010).
Dr. Bhatnagar is a a family medicine physician and clinical epidemiologist with diverse clinical and research experience. Her research focuses on analyzing cohort studies and developing analytic databases from electronic medical records. This work includes analysis of genetic determinants of complex diseases such as hypertension and chronic kidney disease.
Amelia Eastman, DO, HS Assistant Clinical Professor, attended medical school at Western University of Health Sciences and completed residencies in physical medicine and rehabilitation at Baylor College of Medicine, and in preventive medicine at UC San Diego. She is board-certified in the fields of physical medicine and rehabilitation, as well as in preventive medicine. Additionally, Dr. Eastman is a member of the Exercise and Physical Activity Resource Center (EPARC) at the California Institute for telecommunications and Information Technology, and a reviewer for the American Journal of Preventive Medicine. Dr. Eastman's research interest include sports concussion, back pain in workers, and validating objective physical activity and performance measures. She is involved in numerous research trials in the areas of pain, functional decline, fall prevention, and exercise, and has two patents pending for medical inventions to improve functional performance.
Before attending medical school, Dr. Eastman worked as a professional mountain and river guide in South America and New Zealand. In addition, she has lived and worked in health care in Africa and Australia. She has two patents pending for medical inventions to improve functional performance.
James was recently named a Fellow of the John Simon Guggenheim Foundation, one of Foreign Policy's Top 100 Global Thinkers, TechCrunch's Top 20 Most Innovative People in Democracy, and Most Original Thinker of the year by The McLaughlin Group.
His research has been featured in numerous best-of lists including New York Times Magazine's Year in Ideas, Time's Year in Medicine, Discover Magazine's Year in Science, and Harvard Business Review's Breakthrough Business Ideas.
Together with Nicholas Christakis, James wrote a book on social networks for a general audience called Connected. Winner of a Books for a Better Life Award, it has been translated into twenty languages, named an Editor's Choice by the New York Times Book Review, and featured in Wired, Oprah's Reading Guide, Business Week's Best Books of the Year, and a cover story in New York Times Magazine.
Dr. Gunn joined the UCSD Department of Family and Preventive Medicine in 1993 and is currently an Adjunct Professor, Division of Preventive Medicine. He has published numerous articles about sexually transmitted infections (STDs, HIV, and viral hepatitis). His current interests involve integration of prevention services into routine medical care.
His research utilizes epidemiology and biostatistics to understanding mechanisms by which alterations in glucose and mineral metabolism contribute to cardiovascular disease risk among persons with kidney disease. His recent work has focused on the consequences of altered fetuin-A concentrations, a hepatic secretory protein that simultaneously inhibits vascular calcification and promotes insulin resistance. In addition, he works with cystatin-C, a novel endogenous measure of kidney function, determining whether this measure might provide novel insights towards cardiovascular disease mechanisms among persons with early kidney function decline.
Based on her extensive experience in operationalizing community-based research projects, Dr. Pakiz has assisted investigators at the Cancer Prevention and Control Program with the overall conduct of a number of randomized clinical trials. Among the studies she has directed are: the SHAPE study (Survivors' Health and Physical Exercise) which tested the effects of a multifaceted weight loss program in approximately 250 overweight or obese breast cancer survivors; the Orexigen Weight Loss Study, a phase III, double-blind, placebo-controlled study which tested how much more effective an investigational new combination drug therapy can be when combined with a comprehensive lifestyle modification program in helping people lose weight and keep it off. Approximately 900 obese men and women across nine sites in the US participated in this study, including 110 subjects at UCSD; and the FAB Study (Food, Attitudes and Behavior) that tested whether participation in a commercial weight loss program is associated with a greater degree of weight loss compared to usual care or control conditions. Approximately 440 overweight or obese women across four sites in the US participated in this study, including 117 women at UCSD.
Breast Cancer, Breast Cancer Survivors, Cancer, Physical Activity, Weight Loss and Maintenance, Depression and Quality of Life
Dr. Rock’s research efforts are focused on the role of nutritional and dietary factors in the development and progression of cancer, particularly breast cancer, and healthy weight management in adults. Her research efforts address diet composition and weight management, and how diet, adiposity and physical activity affect biomarkers and risk and progression of cancer and other chronic diseases. Dr. Rock is presently responsible for randomized trials funded by the National Institutes of Health (NIH) that are testing whether healthy weight control and modifications in diet and physical activity can alter biological processes, hormonal factors, and biomarkers of disease progression. In addition to also serving as principal investigator for an industry-sponsored randomized clinical trial of a multifaceted weight loss program, she is a co-investigator on several NIH-funded studies that are focused on obesity, various weight loss interventions, and behavioral and metabolic factors associated with disease risk. Dr. Rock also leads the Nutrition Shared Resource of the Moores UCSD Comprehensive Cancer Center, a laboratory and dietary assessment recharge service unit that is focused on identifying and measuring dietary biomarkers and improving dietary assessment methods.
Dr. Rock has served on numerous NIH and USDA review panels and committees, and she currently serves on editorial boards for several peer-reviewed journals. To date, Dr Rock is the author of more than 230 scientific papers and book chapters.
Murray B Stein MD, MPH, FRCPC is Professor of Psychiatry and Family & Preventive Medicine at the University of California San Diego (UCSD), where he directs the Anxiety & Traumatic Stress Disorders Program. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland.
DDr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety disorders especially social phobia, panic disorder, and posttraumatic stress disorder. He has written or co-written over 400 peer-reviewed scientific articles on these topics, including in journals such as The Lancet, Journal of the American Medical Association, American Journal of Psychiatry, and Archives of General Psychiatry. He is co-editor, with Martin Antony PhD, of the Oxford Handbook of Anxiety and Related Disorders (2009). His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Principal Investigator and Director of the Department of Defense-funded (2008-2013) INjury and TRaumatic STress (INTRuST) Consortium, which studies treatments for Posttraumatic Stress Disorder and Traumatic Brain Injury. He is also Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2014) investigating risk factors for suicide and other deployment-related disorders.
Dr. Stein is a member of the Board of Directors of the Anxiety Disorders Association of America (ADAA), a Fellow of the American College of Neuropsychopharmacology (ACNP), Deputy Editor for Anxiety for the journal Depression & Anxiety, and Co-Editor-in-Chief for UpToDate in Psychiatry. He is a member of the editorial board of Psychological Medicine and Biological Psychiatry. Dr. Stein chaired the American Psychiatric Association Workgroup to Revise the Panic Disorder Treatment Guidelines (2006-2008), and is past Scientific Chair of the NIMH Interventions in Mood and Anxiety (ITMA) Review Group (2006-2009). Dr. Stein is a member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and Dissociative Disorders Work Group (2009-present). He is also a member of the Psychopharmacologic Drugs Advisory Committee (PDAC) of the Food and Drug Administration (2011-2014).
Section 'Sub' Navigation:
Page 'Breadcrumb' Navigation: